AI assistant
Sending…
Clene Inc. — Director's Dealing 2021
Feb 4, 2021
34487_dirs_2021-02-03_b9f3cec1-7fdd-4600-975f-d26030b15d8b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Clene Inc. (CLNN)
CIK: 0001822791
Period of Report: 2021-02-01
Reporting Person: Jeong Tae Heum (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-01 | Stock Options (Right to buy) | $6.55 | A | 130000.00 | Acquired | 2031-02-01 | Common Stock (130000.00) | Direct |
Footnotes
F1: This option was granted on February 1, 2021 as an option for 130,000 shares of Common Stock under the Company 2020 Stock Plan, at an exercise price of $6.55 per share. The option
vests in 24 equal installments of Common Stock on the last day of each calendar month, beginning on February 28th, 2021, until such shares are fully vested.
More from Clene Inc.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 4
Annual Report
2026
Mar 17
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 20